DiaSorin SpA 2021 AR2
The report highlights DiaSorin's significant milestones in 2021, most notably the acquisition of Luminex Corporation for approximately $1.8 billion, which expanded its molecular diagnostics and Life Science offerings. Financially, the company delivered strong results with net revenues reaching €1,237,654 thousand, representing a 40.4% increase compared to 2020. On the sustainability front, DiaSorin continued to integrate ESG principles, focusing on employee well-being, occupational health and safety, and environmental protection. The company also launched several innovative diagnostic tests, including solutions for COVID-19 variants and early Lyme disease detection.
Company: DiaSorin SpA
Sector: Health Care
Country: Italy
Year: 2021
Type: AR2
Pages: 227
DiaSorin SpA
Annual Financial Report
The report highlights DiaSorin's significant milestones in 2021, most notably the acquisition of Luminex Corporation for approximately $1.8 billion, which expanded its molecular diagnostics and Life Science offerings. Financially, the company delivered strong results with net revenues reaching €1,237,654 thousand, representing a 40.4% increase compared to 2020. On the sustainability front, DiaSorin continued to integrate ESG principles, focusing on employee well-being, occupational health and safety, and environmental protection. The company also launched several innovative diagnostic tests, including solutions for COVID-19 variants and early Lyme disease detection.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Jan 1, 2021 - Dec 31, 2021
Fiscal Year
2021
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees